Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors

Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors

US Patent 12350349 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conditioning agents for use in allogeneic hematopoietic stem cell transplantatio2025
Compounds and use thereof in methods of treatment2025
Suppression of cytokine release syndrome in chimeric antigen receptor cell thera2025
Suppression of cytokine release syndrome in chimeric antigen receptor cell thera2025
Sulfonamide carboxamide compounds2025
Sulfonamideurea compounds2025
Sulfonamide derivates as NLRP3 inhibitors2024
Sulfonyl acetamides as NLRP3 inhibitors2024
Sulfonamide carboxamide compounds2024
Sulfonamide carboxamide compounds2024
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors2024
Compounds2024